Back to search

Article

A type II anti-CD20 monoclonal antibody efficiently depletes CNS B cells in a mouse model of multiple sclerosis

2021-08-05

Abstract excerpt

<title>Abstract</title> <p>BackgroundSuccessful therapy with anti-CD20 monoclonal antibodies (mAbs) has reinforced the key role of B cells in the immunopathology of multiple sclerosis. While treatment with currently available anti-CD20 mAbs results in rapid and robust elimination of vascular B cells, B cells residing within compartments of the central nervous system (CNS) are not well targeted. The aim of this st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2b06448-21b4-56e6-bc8b-512affa9dd35
DOI
10.21203/rs.3.rs-776877/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A type II anti-CD20 monoclonal antibody efficiently depletes CNS B cells in a mouse model of multiple sclerosisDOI 10.21203/rs.3.rs-776877/v1
Select a neighboring publication to make it the new centre.